HIMS
HEALTHCAREHims Hers Health Inc
AI Insight
What's Moving HIMS Today?
No stock-specific AI insight has been generated for HIMS yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$13.74$70.43
$32.96
Fundamentals
Market Cap$8.2B
P/E Ratio57.1
EPS$-0.09
Dividend Yield—
Dividend / Share—
ROE-2.7%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume12.5M
Avg Volume (10D)—
Shares Outstanding223.1M
HIMS News
27 articles- Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to KnowYahoo Finance·Jun 23, 2026
- Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus BuyYahoo Finance·Jun 23, 2026
- 2 Unpopular Stocks That Deserve a Second Chance and 1 We QuestionYahoo Finance·Jun 23, 2026
- 1 Surging Stock Worth Your Attention and 2 We Find RiskyYahoo Finance·Jun 22, 2026
- HIMS Stock Slides Overnight: Insider Files Share Sale As CEO Teases Oura Wearable IntegrationStocktwits·Jun 22, 2026
- Hims & Hers Health, Inc. (HIMS) Is a Trending Stock: Facts to Know Before Betting on ItYahoo Finance·Jun 19, 2026
- HIMS (NYSE) Form 144: 12,500 and 11,226 vested Class A shares listedStock Titan·Jun 18, 2026
- Living Longer Is Big Business. These Stocks Will Benefit.Yahoo Finance·Jun 18, 2026
- Hims & Hers Rallies With a July FDA Decision LoomingYahoo Finance·Jun 18, 2026
- Hims & Hers Health, Inc. (HIMS) Ascends While Market Falls: Some Facts to NoteYahoo Finance·Jun 17, 2026
- HIMS Stock Gained Nearly 6% On Wednesday — Barclays Sees Breakout Potential After Novo PartnershipStocktwits·Jun 17, 2026
- HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth CatalystStocktwits·Jun 17, 2026
- Hims & Hers Stands to Get a Big Chunk of the $2.2B Peptides MarketYahoo Finance·Jun 16, 2026
- 3 Market-Beating Stocks with Exciting PotentialYahoo Finance·Jun 16, 2026
- HIMS Stock Logs Best Day In 2 Months: Bull Sees Peptides Driving Up To $19B In Annual Revenue By 2030Stocktwits·Jun 16, 2026
- Hims & Hers (HIMS) Climbs 12.5% as Obesity Market Momentum BuildsYahoo Finance·Jun 16, 2026
- Why Hims & Hers Health (HIMS) Is Up 11.0% After GLP-1 Weight Loss Pivot And Telehealth DealYahoo Finance·Jun 15, 2026
- HIMS Stock Set To Test A Crucial Resistance – Is Retail Expecting A Breakout?Stocktwits·Jun 15, 2026
- Fuel Up Your Portfolio with Suja Life’s Farm-to-Bottle Growth StrategyYahoo Finance·Jun 15, 2026
- Doximity (DOCS) Up 11.2% Since Last Earnings Report: Can It Continue?Yahoo Finance·Jun 12, 2026
- The GLP-1 stock nobody is pricing in isn’t a drugmaker247 Wall St·Jun 11, 2026
- Enterprise value to EBITDA ratio of Hims & Hers Health, Inc. Class A – XETR:82WTradingView·Jun 7, 2026
- GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in RevenueThe Motley Fool·May 10, 2026
- SpaceX Goes on $60 Billion AI Buying SpreeThe Motley Fool·Apr 27, 2026
- 3 Sectors to Buy While They’re Down and 1 to Walk Away FromInvesting.com·Apr 7, 2026
- Data Breach Alert: Edelson Lechtzin LLP Investigates Hims & Hers, Inc. Data BreachGlobeNewswire Inc.·Apr 3, 2026
- Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription PlanBenzinga·Mar 31, 2026
All 27 articles loaded
Price Data
Open$32.51
Previous Close$33.54
Day High$34.68
Day Low$32.51
52 Week High$70.43
52 Week Low$13.74
52-Week Range
$13.74$70.43
$32.96
Fundamentals
Market Cap$8.2B
P/E Ratio57.1
EPS$-0.09
Dividend Yield—
Dividend / Share—
ROE-2.7%
Profit Margin-0.6%
Debt / Equity—
Trading
Volume12.5M
Avg Volume (10D)—
Shares Outstanding223.1M
About Hims Hers Health Inc
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeCommon Stock
ExchangeNYSE
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—